| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Asengeprast | SHP-627; FT-011; FT-11 | Phase 2 Clinical | Fibrotech Therapeutics Pty Ltd, University Of Melbourne | Scleroderma, Diffuse; Scleroderma, Systemic | 詳細 |
| Recombinant Human Platelet-derived Growth Factor B(Lynch Regenerative Medicine) | rhPDGF-BB | Phase 2 Clinical | Lynch Regenerative Medicine LLC | Rectal Fistula | 詳細 |
| REGN-13335 | REGN13335; REGN-13335 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Pulmonary Arterial Hypertension | 詳細 |
| HL-217 | HL-217; KR-31831 | Phase 1 Clinical | Korea Research Institute Of Chemical Technology | Macular Degeneration | 詳細 |